← All indications
Ovarian Diseases
Pathological processes of the OVARY.
Subtype terms (8)
More specific conditions that are subtypes of Ovarian Diseases in the MeSH hierarchy.
- Anovulation
20 drugs (16 approved, 4 experimental)
- Menopause, Premature
5 drugs (3 approved, 2 experimental)
- Oophoritis
2 drugs approved
- Ovarian Cysts
12 drugs (10 approved, 2 experimental)
- Ovarian Hyperstimulation Syndrome
27 drugs (23 approved, 4 experimental)
- Ovarian Neoplasms
1163 drugs (312 approved, 851 experimental)
- Ovarian Torsion
2 drugs approved
- Primary Ovarian Insufficiency
46 drugs (26 approved, 20 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (13)
Phase 3 trials (28)
- melatonin
- follitropin alfa
- dehydroepiandrosterone
- doxorubicin
- dydrogesterone
- gemcitabine
- paclitaxel
- goserelin
- platelet-rich plasma
- cabergoline
- urofollitropin
- myoinositol
- niraparib
- prasterone
- plasma rich in growth factors
- ifosfamide
- carboplatin
- bevacizumab
- testosterone
- toremifene
- dostarlimab
- autologous bone marrow derived mesenchymal cells
- menstrual blood stem cells
- triptorelin
- docetaxel
- norgestimate
- calcium gluconate
- ibi354
Phase 2 trials (43)
- anlotinib
- oxytocin
- autologous tumor infiltrating lymphocytes
- mk-1775
- olaparib
- urea
- irinotecan
- temsirolimus
- durvalumab
- eribulin
- entinostat
- fluzoparib
- imatinib
- lapatinib
- hemopoietic stem cell
- aldesleukin
- bleomycin
- pembrolizumab
- lenvatinib
- desogestrel
- oncolytic measles virus encoding thyroidal sodium iodide symporter
- sapanisertib
- cyclophosphamide
- estradiol
- topotecan
- trabectedin
- vinorelbine
- adebrelimab
- fludarabine
- amniotic stem cells
- +13 more
Phase 1 trials (25)
- 89zr-mmot0530a
- galunisertib
- ags-8m4
- mkc1106
- talazoparib
- changtai keli
- progesterone
- elagolix
- nivolumab
- prostate specific membrane antigen
- ipilimumab
- follitropin beta
- stem cells
- allogeneic lymphocytes
- veliparib
- zoledronic acid
- umbilical cord mesenchymal stem cells
- ba-zhen-ke-li
- ubiquinone
- hydroxyethyl starch
- norethindrone
- allorx stem cells®
- ev-pure
- tjaoa101
- ab-1015
Organizations
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (5)